SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
79 hedge funds and large institutions have $464M invested in Syros Pharmaceuticals, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
+15
Holders Change %
+23.44%
% of All Funds
1.62%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
20
Increased
36
Reduced
16
Closed
5
Calls
$941K
Puts
–
Net Calls
+$941K
Net Calls Change
+$330K
Top Buyers
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$27.9M |
| 2 |
BlackRock
New York
|
+$5.4M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.67M |
| 4 |
Two Sigma Investments
New York
|
+$2.63M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.05M |
Top Sellers
| 1 |
AVM
Arch Venture Management
Chicago,
Illinois
|
-$28.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$7.9M |
| 3 |
DM
Deerfield Management
New York
|
-$7.53M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$2.14M |
| 5 |
SCM
Sio Capital Management
New York
|
-$2.09M |
